XRAY
28
2
ZION
65
2
CSX
60
3
UA
50
-9
WDC
47
4
EQIX
64
2
SYY
53
4
ADT
53
3
TDC
80
4
MCHP
41
4
HCA
44
-2
TSCO
49
5
CMG
72
5
XYL
49
4
ISRG
74
-2
FE
50
-2
HPQ
63
6
SNA
68
-2
NAVI
52
5
VTR
47
-7
XRAY
28
2
ZION
65
2
CSX
60
3
UA
50
-9
WDC
47
4
EQIX
64
2
SYY
53
4
ADT
53
3
TDC
80
4
MCHP
41
4
HCA
44
-2
TSCO
49
5
CMG
72
5
XYL
49
4
ISRG
74
-2
FE
50
-2
HPQ
63
6
SNA
68
-2
NAVI
52
5
VTR
47
-7
Financhill
Back

United Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54

UTHR
United Therapeutics

Last Price:
373.01
Seasonality Move:
10.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

United Therapeutics Price Quote

$373.01
+0.12 (+1.54%)
(Updated: November 23, 2024 at 5:59 AM ET)

United Therapeutics Key Stats

Buy
54
United Therapeutics (UTHR) is a Buy
Day range:
$367.90 - $374.02
52-week range:
$208.62 - $417.82
Dividend yield:
0%
P/E ratio:
18.82
P/S ratio:
6.62
P/B ratio:
2.73%
Volume:
254.2K
Avg. volume:
359.2K
1-year change:
61.79%
Market cap:
$16.6B
Revenue:
$2.3B
EPS:
$22.77

How Much Does United Therapeutics Make?

Is United Therapeutics Growing As A Company?

  • What Is United Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.23%
  • What Is United Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.19%

United Therapeutics Stock Price Performance

What Is United Therapeutics 52-Week High & Low?

United Therapeutics Price To Free Cash Flow

Is It Risky To Buy United Therapeutics?

Is United Therapeutics Cash Flow Positive?

  • What Is UTHR Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.1B
  • What Is United Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.3B
  • What Is United Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $582.5M

United Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    UTHR return on invested capital is 17.45%
  • What Is United Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 16.09%
  • What Is UTHR Return On Equity?
    ROE is a measure of profitability and is 19.26%

United Therapeutics Earnings Date & Stock Price

United Therapeutics Competitors

United Therapeutics Dividend Yield

United Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 18.77% -2.19%
Revenue: 22.89% 3.61%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 6
Sell Recommendations: 1
Price Target: 382.22
Upside from Last Price: 2.5%

Major Shareholders

  • How many UTHR shares are owned by institutional investors?
    81.1M UTHR shares are owned by institutional investors
  • How many UTHR shares are owned by insiders?
    125.5K UTHR shares are owned by insiders